• EZ Cap™ Human PTEN mRNA (ψUTP): Assay Guide

  2026-09-02

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP) supports causal cancer research through transient PTEN restoration, Cap 1 translation control, and pseudouridine-enabled mRNA stability enhancement. This guide connects product design with assay interpretation and nanoparticle-based trastuzumab-resistance research.

• Rotenone Beyond Complex I: A Translational Strategy

  2026-09-01

  Rotenone is more than a mitochondrial Complex I inhibitor: it is a strategic perturbation tool for connecting electron-transport failure, mitochondrial stress, apoptosis, autophagy, and neurodegenerative disease biology. This article integrates recent findings on TCAIM-mediated OGDH regulation with practical guidance for designing reproducible cellular and Parkinson’s disease model studies.

• SW033291: Reliable 15-PGDH Assay Workflows

  2026-09-01

  Learn how SW033291 (SKU A8709) can support reproducible 15-PGDH inhibition studies across enzyme, cellular, and regeneration-focused workflows. This scenario-based guide explains solvent selection, concentration planning, controls, and interpretation of PGE2-related readouts.

• Erastin (B1524): Reliable Ferroptosis Assays

  2026-08-31

  Learn how Erastin (SKU B1524) can support interpretable ferroptosis, viability, and oxidative stress experiments through documented handling parameters and mechanism-aware assay design. This scenario-driven guide connects product details with peer-reviewed evidence while addressing solvent, timing, readout, and vendor-selection challenges.

• Calpain Inhibitor II, ALLM: From Protease to Strategy

  2026-08-31

  A mechanistic and translational guide to using Calpain Inhibitor II, ALLM to interrogate cysteine-protease biology, apoptosis, FAK proteolysis, and oncology model design.

• Stattic: Practical STAT3 Inhibition Workflows

  2026-08-30

  Stattic enables mechanism-led studies of STAT3 dimerization, nuclear signaling, apoptosis, and treatment response. This guide translates its use from HNSCC cell assays to a carefully bounded lymphatic endothelial model inspired by recent cadmium research.

• G-15: A G Protein-Coupled Estrogen Receptor Antagonist

  2026-08-29

  G-15 enables selective interrogation of GPR30 signaling without the confounding activity expected from broad classical estrogen receptor blockade. This practical guide connects calcium, PI3K/Akt, proliferation, and neural pain workflows with dosing logic, controls, and troubleshooting strategies.

• Brefeldin A: Workflows for ER Stress Research

  2026-08-28

  Brefeldin A converts secretory-pathway disruption into a practical experimental handle for mapping ER-to-Golgi trafficking, ER stress, apoptosis, and migration phenotypes. This workflow-focused guide shows how to separate acute transport effects from later cell-death responses and how to extend BFA assays toward endothelial injury research.

• EZ Cap EGFP mRNA: A Reporter for Delivery Design

  2026-08-28

  EZ Cap EGFP mRNA 5-moUTP is more than a fluorescence reagent: it can help deconvolute uptake, translation, and carrier performance. This guide connects Cap1 and 5-moUTP chemistry with practical decisions for mRNA delivery and macrophage-targeting studies.

• CX-5461 Workflow for RNA Polymerase I Research

  2026-08-27

  CX-5461 is an RNA polymerase I inhibitor for connecting ribosome biogenesis stress with DNA damage, mitotic catastrophe, autophagy, and senescence. This workflow translates cervical cancer findings into practical concentration design, orthogonal readouts, and cisplatin-combination experiments for cancer research.

• Catalpol for Stroke Translation: From Pathway to Proof

  2026-08-27

  Catalpol, also known as Catalpinoside, offers a mechanistically coherent framework for ischemic stroke research by linking neurogenesis, angiogenesis, and SDF-1α/CXCR4 signaling. This thought-leadership analysis translates the evidence into practical model design, product selection, and translational decision criteria.

• Baricitinib and the IL-6 Signaling Frontier

  2026-08-26

  Spatial proteomics is reframing inflammatory disease as a problem of localized cell-cell signaling. This thought-leadership guide explains how Baricitinib (LY3009104) can translate human PSC observations into mechanistic experiments while preserving selectivity, assay discipline, and translational realism.

• Palonosetron in CINV and RINV: Evidence Update

  2026-08-26

  Fabi and Malaguti’s 2013 review positioned palonosetron hydrochloride as a long-acting 5-HT3 receptor antagonist with particular value for delayed chemotherapy-induced nausea and vomiting after moderately emetogenic chemotherapy. Its main contribution was to integrate receptor pharmacology, clinical trial evidence, combination therapy, and guideline recommendations while identifying unresolved questions in radiotherapy, multiple-day treatment, and breakthrough emesis.

• Chloroquine BA1002: Practical Research Workflow

  2026-08-25

  Chloroquine BA1002 provides a controlled way to perturb lysosomal pH and investigate autophagy-related, immune, anticancer, antiviral, malaria, and rheumatoid arthritis research questions. In the absence of directly matched paper evidence, use the dossier values for assay planning only and do not infer clinical efficacy, pathway selectivity, or performance in an unvalidated model.

• Hyaluronic Acid Sodium Salt for siRNA Assays

  2026-08-25

  Hyaluronic acid sodium salt supports extracellular matrix modeling, cell-migration studies, and HA-coated nanoparticle workflows. This practical guide connects Sodium hyaluronate handling with the preclinical TDRD9-siRNA lung-injury study while separating validated findings from assay-development recommendations.

8565 records 3/571 page Previous Next 12345 下5页 Last page